LifeMD LFMD 深 滬
已收盤 08-07 16:00:00 美东时间
3.56
+0.160
+4.71%
華盛通- 最 高3.64
- 今 開3.41
- 成交量 126.55万股
- 最 低 3.355
- 昨 收 3.40
- 總市值 17.22万
- 52周最高 7.32
- 市盈率 靜 --
- 換手率 2616.75%
- 52周最低 2.56
- 委 比 -9.76%
- 總股本 4.84万
- 歷史最高 33.02
- 量 比 0.73
- 振 幅 8.38%
- 歷史最低 1.14
- 每 手 1
- 風險率 1.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
BTIG Maintains Buy on LifeMD, Lowers Price Target to $9
BTIG analyst David Larsen maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $10 to $9.
08-06 17:28
LifeMD shares are trading lower after the company reported worse-than-expected Q2 financial results and lowered its FY2026 sales guidance. Also, the company issued Q3 sales guidance below estimates.
LifeMD shares are trading lower after the company reported worse-than-expected Q2 financial results and lowered its FY2026 sales guidance. Also, the company issued Q3 sales guidance below estimates.
08-06 05:21
LifeMD Lowers FY2026 Sales Guidance from $220.000M-$230.000M to $205.500M-$212.500M vs $222.046M Est
LifeMD (NASDAQ:LFMD) lowers FY2026 sales outlook from $220.000 million-$230.000 million to $205.500 million-$212.500 million vs $222.046 million estimate.
08-06 04:49
LifeMD Q2 EPS $(0.16) Misses $(0.15) Estimate, Sales $47.300M Miss $49.152M Estimate
LifeMD (NASDAQ:LFMD) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.15) by 6.67 percent. This is a 166.67 percent decrease over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $47.300 million which...
08-06 04:13
LifeMD 2026年第二季度财报：品牌GLP-1转型拖累营收与盈利
LifeMD 2026年第二季度营收4,728万美元，同比下降约3.5%；毛利率升至约89%，但调整后EBITDA亏损353万美元，公司同步下调全年营收与盈利指引。
08-06 00:02
LifeMD to Report Second Quarter 2026 Financial Results on August 5
LifeMD, Inc. (NASDAQ: LFMD), a leading virtual primary care provider, will report financial results for the second quarter ended June 30, 2026, after U.S. markets close on August 5, 2026. A conference call will follow at 4:30 p.m. Eastern time. Participants can join via toll-free (800) 715-9871 or international +1 (646) 307-1963, using conference ID 3616168. A live webcast is available at the provided link. LifeMD offers virtual care services, in...
07-24 20:05
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
LifeMD, Inc. announced that its Board of Directors has authorized a cash dividend of $0.5546875 per share to holders of its 8.875% Series A Cumulative Perpetual Preferred Stock. The dividend will be paid on July 15, 2026, to holders of record at the close of business on July 3, 2026. LifeMD is a leading provider of virtual primary care, offering telemedicine, laboratory, and pharmacy services, as well as specialized treatment across more than 200...
06-23 12:00
LifeMD Partners with Antares on XYOSTED Telehealth Program
The latest update is out from LifeMD ( ($LFMD) ). On June 22, 2026, LifeMD anno...
06-22 21:19
LifeMD To Launch Program For XYOSTED Injection
LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and specialty care today announced a strategic co-marketing collaboration supporting a direct-to-patient self-pay program for XYOSTED® (testosterone enanthate) injection, the only FDA-approved once-weekly subcutaneous testostero...
06-22 20:10
